These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35430749)

  • 1. Screening of the protein C pathway abnormality-related thrombophilia by using thrombomodulin-mediated tissue factor-triggered clot waveform analysis.
    Hashimoto N; Ogiwara K; Shimonishi N; Nakagawa T; Nakajima Y; Furukawa S; Takeyama M; Nogami K
    Eur J Haematol; 2022 Jul; 109(1):100-108. PubMed ID: 35430749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays.
    Hashimoto N; Ogiwara K; Matsumoto T; Furukawa S; Takeyama M; Nogami K
    Blood Coagul Fibrinolysis; 2022 Sep; 33(6):327-336. PubMed ID: 35981254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Elucidation of an altered anticoagulant function due to Factor V abnormality and development of a simple screening assay for thrombophilia].
    Shimonishi N; Nogami K
    Rinsho Ketsueki; 2023; 64(7):654-660. PubMed ID: 37544726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism.
    Toulon P; Adda R; Perez P
    Thromb Res; 2001 Oct; 104(2):93-103. PubMed ID: 11672753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis.
    Sinegre T; Duron C; Lecompte T; Pereira B; Massoulier S; Lamblin G; Abergel A; Lebreton A
    J Thromb Haemost; 2018 Jun; 16(6):1132-1140. PubMed ID: 29577605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden.
    Nogami K; Shinozawa K; Ogiwara K; Matsumoto T; Amano K; Fukutake K; Shima M
    Blood; 2014 Apr; 123(15):2420-8. PubMed ID: 24523236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reduced sensitivity of the ProC Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk.
    Gemmati D; Serino ML; Tognazzo S; Ongaro A; Moratelli S; Gilli G; Forini E; De Mattei M; Scapoli GL
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):691-7. PubMed ID: 11734670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of hereditary thrombophilia.
    Michiels JJ; Hamulyák K
    Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
    Tripodi A
    Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro CR global: an effective screening test for thrombophilia.
    Gupta PK; Ahmed R; Kannan M; Dwivedi SN; Choudhry VP; Saxena R
    Am J Hematol; 2003 Nov; 74(3):208-10. PubMed ID: 14587054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clot Waveform Analysis for Hemostatic Abnormalities.
    Wada H; Shiraki K; Matsumoto T; Shimpo H; Shimaoka M
    Ann Lab Med; 2023 Nov; 43(6):531-538. PubMed ID: 37387486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations.
    Shimonishi N; Ogiwara K; Yoshida J; Horie K; Nakajima Y; Furukawa S; Takeyama M; Nogami K
    Blood Adv; 2023 Jun; 7(12):2831-2842. PubMed ID: 36780344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.
    Dave RG; Geevar T; Mammen JJ; Vijayan R; Mahasampath G; Nair SC
    Indian J Pathol Microbiol; 2021; 64(1):117-122. PubMed ID: 33433420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant response to Agkistrodon contortrix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C pathway.
    Robert A; Eschwège V; Hameg H; Drouet L; Aillaud MF
    Thromb Haemost; 1996 Apr; 75(4):562-6. PubMed ID: 8743179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A.
    Matsumoto T; Nogami K; Tabuchi Y; Yada K; Ogiwara K; Kurono H; Arai N; Shima M
    Haemophilia; 2017 Sep; 23(5):e427-e435. PubMed ID: 28750470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Hereditary Thrombophilia: Performance of Protein C (PC) Testing.
    Marlar RA; Gausman JN
    Methods Mol Biol; 2017; 1646():145-151. PubMed ID: 28804825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor.
    Kottke-Marchant K; Comp P
    Arch Pathol Lab Med; 2002 Nov; 126(11):1337-48. PubMed ID: 12421141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of platelet and phospholipids on clot formation activated by a small amount of tissue factor.
    Wada H; Shiraki K; Matsumoto T; Ohishi K; Shimpo H; Shimaoka M
    Thromb Res; 2020 Sep; 193():146-153. PubMed ID: 32559572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein C deficiency as the major cause of thrombophilias in childhood.
    Ohga S; Ishiguro A; Takahashi Y; Shima M; Taki M; Kaneko M; Fukushima K; Kang D; Hara T;
    Pediatr Int; 2013 Jun; 55(3):267-71. PubMed ID: 23521084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.